Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -61,714 | -222,965 | -44,314 | -181,384 |
| Depreciation Amortization | 3,127 | 10,395 | 2,495 | 9,901 |
| Accounts receivable | N/A | N/A | -91 | N/A |
| Accounts payable and accrued liabilities | 3,754 | N/A | -597 | N/A |
| Other Working Capital | -30,653 | -14,616 | -17,440 | 28,118 |
| Other Operating Activity | 5,098 | 26,567 | 6,771 | 25,615 |
| Operating Cash Flow | $-80,388 | $-200,619 | $-53,176 | $-117,750 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | 61,219 | -3,514 | 152,882 | -3,437 |
| Purchase Of Investment | -321,153 | N/A | -77,350 | N/A |
| Other Investing Activity | 0 | 120,281 | 0 | -54,288 |
| Investing Cash Flow | $-259,934 | $116,767 | $75,532 | $-57,725 |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | -1,115 | N/A | -2,646 | N/A |
| Common Stock Issued | 372,506 | N/A | 22,456 | N/A |
| Other Financing Activity | 7,500 | 28,059 | 750 | 91,327 |
| Financing Cash Flow | $378,891 | $28,059 | $20,560 | $91,327 |
| Beginning Cash Position | 126,038 | 181,831 | 181,831 | 265,979 |
| End Cash Position | 164,607 | 126,038 | 224,747 | 181,831 |
| Net Cash Flow | $38,569 | $-55,793 | $42,916 | $-84,148 |
| Free Cash Flow | ||||
| Operating Cash Flow | -80,388 | -200,619 | -53,176 | -117,750 |
| Capital Expenditure | -3,781 | N/A | -751 | N/A |
| Free Cash Flow | -84,169 | -200,619 | -53,927 | -117,750 |